Compugen Ltd. Logo

Compugen Ltd.

A clinical-stage company developing cancer immunotherapies using an AI platform.

CGEN | TA

Overview

Corporate Details

ISIN(s):
IL0010852080
LEI:
Country:
Israel
Address:
26 Harokmim St., Bldg D, 5885849 Holon

Description

Compugen Ltd. is a clinical-stage therapeutic discovery and development company specializing in cancer immunotherapy. A pioneer in its field, the company leverages a proprietary, broadly applicable, and predictive AI-powered computational discovery platform to identify novel drug targets. Its primary focus is on developing innovative, first-in-class therapeutics designed to modulate the tumor microenvironment and enhance anti-tumor immune responses. Compugen's mission is to advance its pipeline of drug candidates to address patient populations unresponsive to current immunotherapy treatments.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-11-10 15:00
Reports Third Quarter 2025 Results
English 516.5 KB
2025-11-10 15:00
Reports Third Quarter 2025 Results
English 36.4 KB
2025-11-04 15:00
Compugen to Participate in Stifel 2025 Healthcare Conference
English 149.5 KB
2025-11-04 15:00
Compugen to Participate in Stifel 2025 Healthcare Conference
English 36.4 KB
2025-10-27 14:00
Compugen to Release Third Quarter 2025 Results on Monday, November 10, 2025
English 130.8 KB
2025-10-27 14:00
Compugen to Release Third Quarter 2025 Results on Monday, November 10, 2025
English 36.4 KB
2025-10-14 16:00
Immediate Report
English 522.6 KB
2025-10-14 16:00
Immediate Report
English 36.6 KB
2025-10-13 16:00
Other Report or Announcement
English 159.5 KB
2025-10-13 16:00
Other Report or Announcement
English 36.5 KB
2025-10-06 16:00
Other Report or Announcement
English 159.9 KB
2025-10-06 16:00
Other Report or Announcement
English 36.4 KB
2025-09-17 16:00
RESULTS OF A MEETING HELD ON AUGUEST 6, 2025
English 106.4 KB
2025-09-17 16:00
RESULTS OF A MEETING HELD ON AUGUEST 6, 2025
English 36.3 KB
2025-09-08 16:00
to Present Research at the Single Cell Genomics 2025 Conference
English 94.0 KB

Automate Your Workflow. Get a real-time feed of all Compugen Ltd. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Compugen Ltd.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Compugen Ltd. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Alpha Tau Medical Ltd. Logo
Clinical-stage oncology firm developing alpha radiation therapy for solid tumors.
United States of America
DRTS
Alteogen Inc. Logo
Biopharmaceutical firm developing biologics with proprietary drug delivery technologies.
South Korea
196170
AlzeCure Pharma Logo
Develops therapies for severe diseases, focusing on Alzheimer's and pain.
Sweden
ALZCUR
ANAPTYSBIO, INC Logo
Clinical-stage biotech developing immunology therapeutics for inflammatory diseases.
United States of America
ANAB
AngioLab, Inc. Logo
Develops angiogenesis inhibitors for pharmaceuticals and health functional foods.
South Korea
251280
Anixa Biosciences Inc Logo
A clinical-stage biotech developing therapies and vaccines to treat and prevent cancer.
United States of America
ANIX
Annovis Bio, Inc. Logo
A clinical-stage drug platform company developing therapies for neurodegenerative diseases.
United States of America
ANVS
Develops and manufactures DNA-based technologies for genetic medicine and diagnostics.
United States of America
APDN
Aprea Therapeutics, Inc. Logo
Clinical-stage biopharma developing cancer therapeutics via synthetic lethality.
United States of America
APRE
AprilBio Co.,Ltd. Logo
Develops long-acting biologic drugs for autoimmune diseases, oncology, and rare diseases.
South Korea
397030

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.